ArticleFrontiers in immunology2025

CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders.

David A Horwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.